SABS (SAB Biotherapeutics, Inc.) Stock Market Reviews

crown

search

Read and share opinions on SABS (SAB Biotherapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock marke

SABS

SAB Biotherapeutics, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142
Nov 4, 2025
SAB BIO to Participate in Upcoming Investor Conferences
Nov 4, 2025
SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes
Sep 3, 2025
SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Aug 7, 2025
SAB Biotherapeutics Raises $175 Million in Oversubscribed Private Placement; Shares Rise Pre-Bell
Jul 21, 2025
SAB BIO Announces Q1 2025 Financial Results and Provides Company Updates
May 9, 2025
SAB BIO Reports Full Year 2024 Operating and Financial Results
Mar 31, 2025
SAB BIO Announces Positive Topline Phase 1 Clinical Results with Potentially Disease-Modifying T1D Therapy SAB-142
Jan 28, 2025
SAB BIO Announces R&D Webinar Event to Review Phase 1 Topline Results for SAB-142, a Disease-Modifying T1D Therapy
Jan 23, 2025

Reviews